AR077501A1 - A UNITARY PHARMACEUTICAL COMPOSITION, ADMINISTRABLE BY ORAL, THAT INCLUDES THE COMBINATION OF COMPOUNDS (ALFA S) -N, N-DIMETIL-ALFA- [2- (1-NAFTALENILOXI) ETIL] BENZENE-METHANAMINE AND 1 - [[3- (4,7-DIHIDRO-1-METIL-7-OXO-3-PROPIL-1H-PIRAZOLO [4,3-D] PYRIMIDIN-5-IL) -4-ETOXYPHENYL] SULFONYL] -4-METHYLPIPERAZI - Google Patents
A UNITARY PHARMACEUTICAL COMPOSITION, ADMINISTRABLE BY ORAL, THAT INCLUDES THE COMBINATION OF COMPOUNDS (ALFA S) -N, N-DIMETIL-ALFA- [2- (1-NAFTALENILOXI) ETIL] BENZENE-METHANAMINE AND 1 - [[3- (4,7-DIHIDRO-1-METIL-7-OXO-3-PROPIL-1H-PIRAZOLO [4,3-D] PYRIMIDIN-5-IL) -4-ETOXYPHENYL] SULFONYL] -4-METHYLPIPERAZIInfo
- Publication number
- AR077501A1 AR077501A1 ARP100102701A AR077501A1 AR 077501 A1 AR077501 A1 AR 077501A1 AR P100102701 A ARP100102701 A AR P100102701A AR 077501 A1 AR077501 A1 AR 077501A1
- Authority
- AR
- Argentina
- Prior art keywords
- alfa
- pharmaceutical composition
- compounds
- combination
- pyrimidin
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 3
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 title 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 title 1
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 abstract 3
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- USRHYDPUVLEVMC-FQEVSTJZSA-N dapoxetine Chemical compound C1([C@H](CCOC=2C3=CC=CC=C3C=CC=2)N(C)C)=CC=CC=C1 USRHYDPUVLEVMC-FQEVSTJZSA-N 0.000 abstract 1
- 229960005217 dapoxetine Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
- 229960003310 sildenafil Drugs 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composicion farmacéutica unitaria, administrable por vía oral, que comprende, al menos, una combinacion de los compuestos (alfaS)-N,N-Dimetil-alfa-[2-(1-naftaleniloxi)etil]benceno- metanamina y 1-[[3-(4,7-Dihidro-1-metil-7-oxo-3-propil-1H-pirazolo[4,3-d]pirimidin-5-il)-4-etoxifenil]sulfonil]-4-metilpiperazina, sus sales, solvatos o derivados farmacéuticamente aceptables. De preferencia, la composicion farmacéutica de la invencion se encuentra en forma de una composicion farmacéutica solida. Uso de la combinacion de los compuestos Dapoxetina y Sildenafil en la elaboracion de medicamentos destinados al tratamiento de una disfuncion sexual.Unitary pharmaceutical composition, orally administrable, comprising at least one combination of the compounds (alphaS) -N, N-Dimethyl-alpha- [2- (1-naphthalenyloxy) ethyl] benzene methanamine and 1 - [[ 3- (4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo [4,3-d] pyrimidin-5-yl) -4-ethoxyphenyl] sulfonyl] -4-methylpiperazine, sus pharmaceutically acceptable salts, solvates or derivatives. Preferably, the pharmaceutical composition of the invention is in the form of a solid pharmaceutical composition. Use of the combination of the compounds Dapoxetine and Sildenafil in the preparation of medicines for the treatment of sexual dysfunction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP100102701 AR077501A1 (en) | 2010-07-26 | 2010-07-26 | A UNITARY PHARMACEUTICAL COMPOSITION, ADMINISTRABLE BY ORAL, THAT INCLUDES THE COMBINATION OF COMPOUNDS (ALFA S) -N, N-DIMETIL-ALFA- [2- (1-NAFTALENILOXI) ETIL] BENZENE-METHANAMINE AND 1 - [[3- (4,7-DIHIDRO-1-METIL-7-OXO-3-PROPIL-1H-PIRAZOLO [4,3-D] PYRIMIDIN-5-IL) -4-ETOXYPHENYL] SULFONYL] -4-METHYLPIPERAZI |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP100102701 AR077501A1 (en) | 2010-07-26 | 2010-07-26 | A UNITARY PHARMACEUTICAL COMPOSITION, ADMINISTRABLE BY ORAL, THAT INCLUDES THE COMBINATION OF COMPOUNDS (ALFA S) -N, N-DIMETIL-ALFA- [2- (1-NAFTALENILOXI) ETIL] BENZENE-METHANAMINE AND 1 - [[3- (4,7-DIHIDRO-1-METIL-7-OXO-3-PROPIL-1H-PIRAZOLO [4,3-D] PYRIMIDIN-5-IL) -4-ETOXYPHENYL] SULFONYL] -4-METHYLPIPERAZI |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR077501A1 true AR077501A1 (en) | 2011-08-31 |
Family
ID=44581760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100102701 AR077501A1 (en) | 2010-07-26 | 2010-07-26 | A UNITARY PHARMACEUTICAL COMPOSITION, ADMINISTRABLE BY ORAL, THAT INCLUDES THE COMBINATION OF COMPOUNDS (ALFA S) -N, N-DIMETIL-ALFA- [2- (1-NAFTALENILOXI) ETIL] BENZENE-METHANAMINE AND 1 - [[3- (4,7-DIHIDRO-1-METIL-7-OXO-3-PROPIL-1H-PIRAZOLO [4,3-D] PYRIMIDIN-5-IL) -4-ETOXYPHENYL] SULFONYL] -4-METHYLPIPERAZI |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR077501A1 (en) |
-
2010
- 2010-07-26 AR ARP100102701 patent/AR077501A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP20070854A (en) | HETEROARYL TETRACYCLIC COMPOUNDS | |
| UY38602A (en) | CONDENSED TRICYCLIC COMPOUNDS | |
| ECSP066990A (en) | FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE PRINCIPLE CONTAINING VARDENAFILO | |
| HN2004000490A (en) | PROCEDURE FOR THE PREPARATION OF AN ORALLY ADMINISTRABLE SOLID PHARMACEUTICAL COMPOSITION | |
| ECSP11011198A (en) | SULFONAMIDE DERIVATIVES | |
| CO2022012884A2 (en) | Fused Amino Pyrimidine Compounds | |
| CR9954A (en) | PIRAZINE DERIVATIVES | |
| AR124688A2 (en) | A PYRIMIDINE SULFONAMIDE OR A TAUTOMER THEREOF, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | |
| PE20241581A1 (en) | CRYSTALLINE FORMS OF A BRUTON TYROSINE KINASE INHIBITOR | |
| AR065797A1 (en) | USES AND DERIVATIVES OF 1- (2- (2,4- DIMETILFENILSULFANIL) PHENYL) PIPERAZINE | |
| CL2012000033A1 (en) | Compounds n- (3- (4as, 7as) -2-amino-4a, 5,7,7a-tetrahydro-4h-furo [3,4-d] [1,3] thiazin-7a-yl) -4- fluorophenyl) -5-fluoropiconylamide, bace inhibitor; pharmaceutical composition comprising them, use of the compound for the treatment of Alzheimer's disease. | |
| CL2013001558A1 (en) | The use of s1p receptor modulating or agonist compounds to decrease heart rate by approximately 2 beats / minute; method to reduce, prevent or limit a negative chronotropic effect; a pharmaceutical kit | |
| UY32203A (en) | AMINO PIRIMIDINAS AND ITS USE IN THERAPY | |
| UY30333A1 (en) | USE OF FLIBANSERINE FOR THE TREATMENT OF SEXUAL DESIRE POSMENOPAUSIC DISORDERS | |
| CL2007001918A1 (en) | SUBSTITUTED HETEROARILY DERIVATIVE COMPOUNDS; METHOD FOR THE PREPARATION OF COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, DEPRESSION, ALZHEIMER'S DISEASE AND HYPERTENSION BETWEEN OTHERS. | |
| DOP2010000387A (en) | PIRAZOLIC COMPOUNDS 436 | |
| ECSP088296A (en) | THERAPEUTIC COMPOUNDS | |
| MX2023000812A (en) | BENZOAZEPINE ANALOGS AS INHIBITING AGENTS OF BRUTON'S TYROSINE KINASE. | |
| UY29899A1 (en) | USE OF FLIBANSERINE FOR THE TREATMENT OF PREMENOPAUSIC SEXUAL DESIRE DISORDERS | |
| GT200500309A (en) | DERIVATIVES OF SULFONILBENCILIMIDAZOL | |
| DOP2019000070A (en) | AZA-INDAZOLE COMPOUNDS FOR USE IN INJURIES OF TENDONS AND / OR LIGAMENTS | |
| CR10842A (en) | DERIVATIVES OF ACETYLENE AND ITS USE FOR THE UNION TO AMYLOID PLATES AND ITS DIAGNOSIS BY IMAGES | |
| AR062784A1 (en) | TREATMENT OF THE VERTIGES WITH ACETIL -L- LEUCINA | |
| UY29818A1 (en) | NEW AZETIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND THERAPEUTIC USES | |
| AR069009A1 (en) | ARYLINDENOPIRIMIDINS AND THEIR USE AS ANTAGONISTS OF THE ADENOSINE A₂A RECEPTOR |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |